Award to golden state medical supply, INC. For lacosamide tablets for the base year with four one-year options. Ordering period is 2/13/2022 through 2/12/2024.

Active Indefinite Delivery Contract Awarded Last action

Contract number
36E79723D0008
Awardee
Awarding agency
Task orders
0

Award facts

Opportunity
Last date to order 96% complete
IDV ceiling
$4,928,686.10
Award type
Single award
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition · 4 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price

Award details come from SAM.gov/FPDS.

About this IDV

The National Acquisition Center awarded a single-award indefinite-delivery contract to Golden State Medical Supply, Inc. on February 13, 2023, with a ceiling of $4,928,686.10 for lacosamide tablets, with ultimate completion on December 31, 2026.

The contract carries no set-aside. The ordering period runs from February 13, 2022, through February 12, 2024, with four one-year options available. The originating solicitation, posted August 30, 2022, with a due date of September 27, 2022, requested lacosamide tablets for the base year.

Modification P00008 recognized Golden State Medical Supply's transition from small-business to large-business status in accordance with FAR 19.301(a)(2). The contractor operates under NAICS 325412 (Pharmaceutical Preparation Manufacturing) and PSC 6505 (Drugs and Biologicals), supplying prescription medications and pharmaceutical products to federal healthcare systems. Place of performance is Camarillo, California.

Transactions

Action Obligated Date
Other Administrative Action P00008 · Modification P00008 is issued to recognize golden state medical supply, INC.'S change from a small business to a large business in accordance with far… $0
Supplemental Agreement for work within scope P00007 · Implementing EO 14398 DEI discrimination $0
Other Administrative Action P00006 · Change point of contact. $0
Exercise an Option P00005 · Exercise of option year three for contract 36E79723D0008 for lacosamide tablets with no price change. Period of performance is 02/13/2026 - 02/12/2027. $0
Exercise an Option P00004 · Exercise of option year two for contract 36E79723D0008 for lacosamide tablets with no price change. Period of performance is 02/13/2025 - 02/12/2026. $0
Supplemental Agreement for work within scope P00003 · Update to cost recovery fee (CRF) and submission of quarterly sales reports. $0
Exercise an Option P00002 · Exercise of option year one for contract 36E79723D0008 for lacosamide tablets with no price change. Period of performance is 02/13/2024 - 02/12/2025. $0
Other Administrative Action P00001 · Incorporation of drug supply chain security act (DSCSA) language to contract. $0
Original award $0

Quick answers

Who was awarded contract 36E79723D0008?

36E79723D0008 was awarded to Golden State Medical Supply, Inc. by National Acquisition Center (Headquarters) on February 13, 2023.

How much is contract 36E79723D0008 worth?

36E79723D0008's own ceiling is $4,928,686.

Who can order from contract 36E79723D0008?

36E79723D0008 is a single award indefinite delivery contract.

Was contract 36E79723D0008 competed?

The extent of competition for 36E79723D0008 was full and open competition. The government received 4 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV